Novel medical therapies for pediatric heart failure

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Treatment of pediatric heart failure is challenging because of the heterogeneity in etiology and the lack of extensive, standardized guidelines. Many current treatment regimens are based on anecdotal evidence or experience in adult populations. Mortality rates can be high in children with heart failure, and studies of treatment strategies for improving outcome are ongoing. Newer strategies for pediatric populations may involve optimizing established regimens that have been successful in adults or validating alternative intravenous therapies, such as levosimendan and nesiritide, which have shown promise in early studies. As the technology continues to improve, ventricular assist devices are being used more frequently in children. Studies are underway to evaluate the success of cardiac resynchronization therapy in children with ventricular dyssynchrony. In addition, indirect strategies that target other organ systems may improve cardiac function in a global approach to treating pediatric patients. This article will summarize current therapies and present options for newer treatment strategies for the increasing population of children with heart failure.

Original languageEnglish (US)
Pages (from-to)61-66
Number of pages6
JournalProgress in Pediatric Cardiology
Volume23
Issue number1-2
DOIs
StatePublished - Sep 1 2007
Externally publishedYes

Fingerprint

Heart Failure
Pediatrics
Population
Therapeutics
Cardiac Resynchronization Therapy
Heart-Assist Devices
Brain Natriuretic Peptide
Complementary Therapies
Guidelines
Technology
Mortality

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Cardiology and Cardiovascular Medicine

Cite this

Novel medical therapies for pediatric heart failure. / Jefferies, John.

In: Progress in Pediatric Cardiology, Vol. 23, No. 1-2, 01.09.2007, p. 61-66.

Research output: Contribution to journalArticle

@article{3e39aaa2872540df8c2ad6435af66fa5,
title = "Novel medical therapies for pediatric heart failure",
abstract = "Treatment of pediatric heart failure is challenging because of the heterogeneity in etiology and the lack of extensive, standardized guidelines. Many current treatment regimens are based on anecdotal evidence or experience in adult populations. Mortality rates can be high in children with heart failure, and studies of treatment strategies for improving outcome are ongoing. Newer strategies for pediatric populations may involve optimizing established regimens that have been successful in adults or validating alternative intravenous therapies, such as levosimendan and nesiritide, which have shown promise in early studies. As the technology continues to improve, ventricular assist devices are being used more frequently in children. Studies are underway to evaluate the success of cardiac resynchronization therapy in children with ventricular dyssynchrony. In addition, indirect strategies that target other organ systems may improve cardiac function in a global approach to treating pediatric patients. This article will summarize current therapies and present options for newer treatment strategies for the increasing population of children with heart failure.",
author = "John Jefferies",
year = "2007",
month = "9",
day = "1",
doi = "10.1016/j.ppedcard.2007.05.004",
language = "English (US)",
volume = "23",
pages = "61--66",
journal = "Progress in Pediatric Cardiology",
issn = "1058-9813",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Novel medical therapies for pediatric heart failure

AU - Jefferies, John

PY - 2007/9/1

Y1 - 2007/9/1

N2 - Treatment of pediatric heart failure is challenging because of the heterogeneity in etiology and the lack of extensive, standardized guidelines. Many current treatment regimens are based on anecdotal evidence or experience in adult populations. Mortality rates can be high in children with heart failure, and studies of treatment strategies for improving outcome are ongoing. Newer strategies for pediatric populations may involve optimizing established regimens that have been successful in adults or validating alternative intravenous therapies, such as levosimendan and nesiritide, which have shown promise in early studies. As the technology continues to improve, ventricular assist devices are being used more frequently in children. Studies are underway to evaluate the success of cardiac resynchronization therapy in children with ventricular dyssynchrony. In addition, indirect strategies that target other organ systems may improve cardiac function in a global approach to treating pediatric patients. This article will summarize current therapies and present options for newer treatment strategies for the increasing population of children with heart failure.

AB - Treatment of pediatric heart failure is challenging because of the heterogeneity in etiology and the lack of extensive, standardized guidelines. Many current treatment regimens are based on anecdotal evidence or experience in adult populations. Mortality rates can be high in children with heart failure, and studies of treatment strategies for improving outcome are ongoing. Newer strategies for pediatric populations may involve optimizing established regimens that have been successful in adults or validating alternative intravenous therapies, such as levosimendan and nesiritide, which have shown promise in early studies. As the technology continues to improve, ventricular assist devices are being used more frequently in children. Studies are underway to evaluate the success of cardiac resynchronization therapy in children with ventricular dyssynchrony. In addition, indirect strategies that target other organ systems may improve cardiac function in a global approach to treating pediatric patients. This article will summarize current therapies and present options for newer treatment strategies for the increasing population of children with heart failure.

UR - http://www.scopus.com/inward/record.url?scp=34547436246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547436246&partnerID=8YFLogxK

U2 - 10.1016/j.ppedcard.2007.05.004

DO - 10.1016/j.ppedcard.2007.05.004

M3 - Article

VL - 23

SP - 61

EP - 66

JO - Progress in Pediatric Cardiology

JF - Progress in Pediatric Cardiology

SN - 1058-9813

IS - 1-2

ER -